Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

FutuRx

FutuRx
ACCEL/INCU INVESTOR TYPE
Active STATUS
6 INVESTMENTS
6 PORTFOLIO
Description

FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. The firm invests in new biotechnology products.

Investor Status
Actively Seeking New Investments
Year Founded
2014
Primary Investor Type
Accelerator/Incubator
Primary Office
  • Weizmann Science Park
  • Ness Ziona
  • Israel

FutuRx Investments (6)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Mitoconix Bio 01-Aug-2016 Accelerator/Incubator Drug Discovery Pre-Clinical Trials 00000 000000 00.0
00 000000000000 01-Mar-2015 000000000000 Drug Discovery Startup
000000 14-Jan-2015 000000000000 Other Devices and Supplies Startup
0000 00000000000 12-Jan-2015 000000000000 Drug Discovery Startup
Biomx Accelerator/Incubator Drug Discovery Pre-Clinical Trials
ImmPACT-Bio Accelerator/Incubator Drug Discovery Startup
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore FutuRx’s full profile, request a free trial.

FutuRx Team (2)

Name Title Deals Funds Boards Office Contact
Info
Einat Zisman Ph.D Chief Executive Officer 0 0 Ness Ziona, Israel
Daria Mochly-Rosen Ph.D Founder 0 Ness Ziona, Israel